|
|
Ziagen (Abacavir)
| Brand Name: |
Ziagen |
| Generic Name: |
Abacavir, ABC |
| Adult Single Dose: |
One 300-mg tablet (twice a day) or two 300-mg
tablets (once a day) |
| Food & Liquid Restrictions: |
None |
| Drug Class: |
NRTI |
The Basics
- An Overview of Ziagen (Abacavir) (Regularly Updated)
To read PDF, click here
From U.S. National Institutes of Health
- Abacavir (Ziagen) (October 1, 2009)
To read PDF, click here
From AIDS InfoNet
- Ziagen (March/April 2009)
To read PDF, click here
In Positively Aware, from Test Positive Aware Network
- Ziagen (Abacavir) (September 28, 2008)
Basic information on dosing schedules and side effects.
From U.S. Department of Veterans Affairs
- Abacavir (Ziagen) (July 15, 2008)
From AIDS Treatment Data Network
- Patient Information About Ziagen (Abacavir) (PDF) (July 2008)
From GlaxoSmithKline
- Ziagen (Abacavir) (May 2005)
To read PDF, click here
From The Center for AIDS
- Drug Interactions: Abacavir (August 2004)
From Project Inform
- HEPPigram: Management of the Abacavir Hypersensitivity Syndrome (AHS) (January 2002)
[Archived Article]
To read PDF, click here
In HEPP News, from Brown Medical School
News
- Ziagen 300 mg Scored Tablet Facilitates Pediatric Treatment of Infection With HIV (December 19, 2008)
From U.S. Food and Drug Administration
- GlaxoSmithKline Announces New Program to Provide Financial Assistance for Eligible HIV Patients in the U.S. (November 11, 2008)
If you live in the United States, use private health insurance and take Combivir (AZT/3TC), Epzicom (abacavir/3TC, Kivexa), Lexiva (fosamprenavir, Telzir) or another HIV drug made by GlaxoSmithKline, you may have a chance to save a nice chunk of change.
From GlaxoSmithKline
- Important Safety-Related Label Update for Ziagen (Abacavir Sulfate) (July 18, 2008)
From U.S. Food and Drug Administration
- Ziagen's Heart Attack Link: How Long Has Glaxo Known? (May 12, 2008)
In The Independent
- Guidelines Panel Responds to Abacavir Data (April 10, 2008)
From Project Inform
- Early Communication About an Ongoing Safety Review of Ziagen (Abacavir) and Videx (Didanosine) (March 27, 2008)
From U.S. Food and Drug Administration
- Ziagen Pills Found in Fake Combivir Packaging (March 29, 2007)
To read PDF, click here
From GlaxoSmithKline
- Two New Fixed-Dose Combinations Approved (August 2, 2004)
From U.S. Food and Drug Administration
- Drug Development News: Fixed-Dose Combinations (May/June 2004)
The Food and Drug Administration's fast-track approval process for fixed-dose combinations is about to bear fruit.
In GMHC Treatment Issues, from Gay Men's Health Crisis
- New Warnings About Hypersensitivity to Ziagen (Abacavir) (September 7, 2000)
[Archived Article]
In STEP Ezine, from Seattle Treatment Education Project
- Ziagen (Abacavir): New Warning on Restarting (August 4, 2000)
[Archived Article]
In AIDS Treatment News, from AIDS Treatment News
- Important Drug Warning: Severe Hypersensitivity Reactions Following Reintroduction With Ziagen (Abacavir Sulfate) Products (July 2000)
[Archived Article]
From U.S. Food and Drug Administration
- Hypersensitivity Reaction and Abacavir (Ziagen) (April 2000)
[Archived Article]
In What's New, from Project Inform
- Abacavir Warning: Certain Respiratory Symptoms Can Indicate Hypersensitivity Reaction (February 18, 2000)
[Archived Article]
From AIDS Treatment News
- Treatment Briefs: Changes in Warning on Abacavir Hypersensitivity (Winter 1999/2000)
[Archived Article]
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Ziagen (Abacavir) Approved: Caution Essential (January 8, 1999)
[Archived Article]
From AIDS Treatment News
- FDA Approves Abacavir for HIV-1 Infection (December 18, 1998)
[Archived Article]
From U.S. Food and Drug Administration
- New Drug Pricing: Progress on World AIDS Day? (December 4, 1998)
[Archived Article]
Abacavir price announced.
From AIDS Treatment News
- Abacavir (Ziagen) Approval Recommended (November 6, 1998)
[Archived Article]
From AIDS Treatment News
- Abacavir's Trials and Tribulations (November 1998)
[Archived Article]
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Abacavir Struggles to Carve Out Niche (October 1998)
[Archived Article]
In TAGline, from Treatment Action Group
- Abacavir More Widely Available March 23 (March 20, 1998)
[Archived Article]
In AIDS Treatment News, from AIDS Treatment News
- Abacavir at Last (March 1998)
[Archived Article]
In GMHC Treatment Issues, from Gay Men's Health Crisis
- 1592 (Abacavir): Do Not Rechallenge After Hypersensitivity Reaction (December 19, 1997)
[Archived Article]
In AIDS Treatment News, from AIDS Treatment News
- 1592 Access: Larger Program Planned (November 21, 1997)
[Archived Article]
In AIDS Treatment News, from AIDS Treatment News
- AIDS Dementia: 1592 Now More Available (November 7, 1997)
[Archived Article]
In AIDS Treatment News, from AIDS Treatment News
- 1592 Adult Compassionate-Use Program Announced (August 1, 1997)
[Archived Article]
From AIDS Treatment News
- Pediatric 1592 Compassionate Use Program Begins (July 18, 1997)
[Archived Article]
From AIDS Treatment News
- 1592: Protests on Small Access Program (June 20, 1997)
[Archived Article]
From AIDS Treatment News
- 1592 -- Where Are You? (June/July 1997)
[Archived Article]
From PWA Health Group
- 1592: Where Are You? People With AIDS Demand Real Expanded Access for Glaxo's New AIDS Drug 1592 (June 1997)
[Archived Article]
From PWA Health Group
- 1592: Small Distribution Programs Begin June, July (May 16, 1997)
[Archived Article]
From AIDS Treatment News
- 1592: Consensus Letter on Access to New Glaxo Drug (December 20, 1996)
[Archived Article]
In AIDS Treatment News, from AIDS Treatment News
- 1592 -- New Experimental Antiretroviral (August 23, 1996)
[Archived Article]
In AIDS Treatment News, from AIDS Treatment News
|
Advertisement
|
E-Mail
Glossary
Share